Chih-Lung Chen, Jhang-Sian Yu, Chia-Hung Lin, Po-Fan Chu, Lin-Yu Liao, Wan-Chen Tsai, Yi-Han Dai, Ming-Chin Ko, Annie Yi-Ting Lai, Chun-Yu Lin, Wei-Ting Chen, Ying-Tsen Tung, Kuan-Hung Chen, Shao-Ju Weng, Pei-Kai Chen, Yi-Chiao Tseng, Ke-Hsun Hsu, Fang-Pei Chang, Fu-Fei Hsu, Yi-Ting Lai, Shiou-Ling Jian, Chien-Yu Hsu, Darien Zhing Herr Chan, Yo-Cheun Lin, Jin-Yi Lu, Hsin-Hua Cho, Cheng-Kai Wang, Lee-Yieng Lim, Tzu-Chien Kuo, Yun Gao, Pei-Chun Wu, Ta-Hsun Liao, Lien-Szu Wu, Jen-Chih Chi, Ching-Ying Huang, Ao Hu, MinHong Yan, Haitao Wang, Alex Shih-Min Huang. "iPSC-derived, multiplex-engineered CD8αβT cells deliver antigen-specific, potent, and durable tumor cytotoxicity without CD4αβT support – powering scalable, off-the-shelf allogeneic αβT cell therapy in hematological malignancies." Blood, 2025. doi:10.1182/blood-2025-2327